chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Got the vaccine then got the shingles/suspected vaccination failure; shingles; This case was reported by a consumer and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional details were reported as follows: The case was reported by the patient. The age at vaccination was not reported. The patient got the vaccine then got the shingles. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation were unknown at the time of reporting. No contact details were available.
Pt. came in on 1/2/18, and said she thought she had Brachial neuritis from her flu shot. She had not seen a MD about it, but was planning on seeing him soon.
rt arm swollen to twice nl size w/swelling extending onto neck; arm feels hot but is not red; face flushed but temp never >98.6; ER visit on Pm APAP only tx advised; restless all noc; sleeping more than usual;
102 fever; Sore arm at site; Muscle soreness; Skin sensitivity; Headache; Fatigue/Extremely tired; Breathless; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 50 year-old female patient received bnt162b2 (BNT162B2) (Lot number: Fc3183) at the age of 50 years as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "COVID-19" (unspecified if ongoing), notes: prior to vaccination, the patient was diagnosed with COVID-19. The patient's concomitant medications were not reported. The following information was reported: PYREXIA (non-serious), outcome "unknown", described as "102 fever"; VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "Sore arm at site"; MYALGIA (non-serious), outcome "unknown", described as "Muscle soreness"; HYPERAESTHESIA (non-serious), outcome "unknown", described as "Skin sensitivity"; HEADACHE (non-serious), outcome "unknown", described as "Headache"; FATIGUE (non-serious), outcome "unknown", described as "Fatigue/Extremely tired"; DYSPNOEA (non-serious), outcome "unknown", described as "Breathless". Relevant laboratory tests and procedures are available in the appropriate section. No follow-up attempts are possible. No further information is expected.
pt devel closely distributed vesicles over feet, legs, thighs, hands, forearms (resembles smallpox, i.e. all lesions in similar phase of eruption)
I was waiting my 15 minutes after receiving my vaccine. I had my feet up on the chair and when I got up and made my first step, I had a terrible pain in my leg. I limped to my car and sat in my car for an additional 10 minutes. While sitting there, my vision was blurred. It cleared up in about 15 minutes and I drove home. The rest of the day, I walked around the house with a limp and I had swelling in the back of my knee. I went to my GP and he gave me a D-Dimer test. They called a few hours later with the results that it was positive for a blood clot. There was an ultrasound performed on both legs to locate the blood clot. No one was able to locate the blood clot and I was not given any medication for it. I called the doctor, a couple of days later. and she had me come in and she performed another D-Dimer test and that one came back negative. About two months after seeing her, I was still experiencing weakness in my leg. There was a lot of swelling behind my left leg, but everything is fine now.
Extreme dizziness.  Condition lasted for a week, and gradually subsided, and became intermittent.  It was noticeable when rising from a prone position - such as getting out of bed.   I contacted my rheumatologist, who advised me to stop taking the methotrexate for two weeks after receiving the vaccine.  I have not resumed the methotrexate, and have received the second dose of the Pfizer vaccine on February 28.  No recurrence of the dizziness after the second dose.
Subsequent to receiving one dose of varicella virus vaccine live on 9/24/98, the pt experienced chickenpox with a rash on the back and stomach on 3/4/99. Itching was also noted.
Here for being ill for several weeks. Seen in ED, cultures negative, CBC noted to have a WBC of 2.7 - nl hgb/plt, nl ANC but low ALC. The father reports this is day 16 of fever. On 12/17 he had a flu shot in our office. Fever started on 12/18 with a rash that looked like hives to the family. They thought that the rash may have been from eating a peanut butter cookie. The rash was itchy. When he had the rash he had swelling of his hands. His rash has been up to 105 and has been daily. He has been to the ED and to urgent care, at one visit they noted that his eyes were injected but there was no d/c. His neck has hurt (back of neck) but no neck swelling noted. + chills, + one day loose stool + loss of energy (sleeping a lot). No bruising, no bleeding, no seizures, no photophobia, no ear pain, no emesis.
Narrative:  COVID infection following COVID vaccine series 01/11, Pfizer, dose #1 03/04, Pfizer, dose #2 12/30 COVID swab, result: detected 12/24 pt cc: exposure: unknown
Woke up in the morning after vaccine 9/30/21 with sore arm, migraine head ache, right side of neck pain, stiffness. Has continued with headaches mild to migraine until 10/11/21. Takes prescription migraine medicine x 2 doses since flu vaccine.  Last taken on 10/10/21 evening.  Called Employee Health dept. on 10/11/21 to report still, "not feeling well."  Asking when OK to take the Covid booster?
Per internal reported event (submitted 1/18/21): 2nd dose of COVID vaccine on 1/10/21. Approximately 6-8 hours after injection my right wrist began to have pain, specifically when gripping objects. Pain worsened through the next day. I bought a brace and used ibuprofen and heat / ice to try to alleviate the pain. Still having pain despite rest, ice, compression and immobilization.
Shaking chills, Lethargy, Acute fatigue, Diarrhea, Loss of appetite, probable fever for 5 to 7 days
Upset stomach, poor appetite (eating only crackers & jello for 3 days), watery diarrhea, fatigue, migraine.
Information has been received from a registered nurse concerning a 16 year old female who on 13-NOV-2006 was vaccinated with the first dose of GARDASIL (Lot# 653978/0955F). On 15-JAN-2007 the patient was vaccinated with the second dose of GARDASIL (Lot# 655619/1427F). On 09-JUL-2007 she was vaccinated with the third dose of GARDASIL (Lot# 657622/0388U). The patient experienced vomiting and dizziness for one day following all three doses of GARDASIL. The patient recovered from the events. Additional information has been requested. This is in follow-up to report (s) previously submitted on 10/12/2007; 1/7/2008. Information has been received from a registered nurse concerning a 17 year old female patient with an allergy to ROCEPHIN and BIAXIN and a history of pediatric PVC's (premature ventricular contractions) who on 13-NOV-2006 at 15:45, was vaccinated into the left arm with a first dose of GARDASIL vaccine (lot# 653978/0953F). On 15-JAN-2007 at 15:30, the patient was vaccinated into the left arm with the second dose of GARDASIL vaccine (Lot# 655619/1427F). On 09-JUL-2007 at 10:00am, she was vaccinated into the left arm with a third dose of GARDASIL vaccine (Lot# 657622/0388U). The patient experienced vomiting and dizziness for one day following all three doses of GARDASIL vaccine. Follow up information stated on 13-NOV-2006 within 15 minutes after the vaccination, the patient experienced syncope following each injection which seems to get worse each injection and she could be dizzy for several hours. Unspecified medical attention was sought. At the time of this report, the patient's outcome was unknown. No product quality complaint was involved. Additional information is not expected. This is in follow-up to report (s) previously submitted on 10/12/2007. Information has been received from a registered nurse concerning a 16 year old female who on 13-NOV-2006, was vaccinated with a first dose of GARDASIL (Lot# 653978/0955F). On 15-JAN-2007 the patient was vaccinated with the second dose of GARDASIL (Lot# 655619/1427F). On 09-JUL-2007, she was vaccinated with the third dose of GARDASIL (Lot# 657622/0388U). The patient experienced vomiting and dizziness for one day following all three doses of GARDASIL. At the time of this report, the patient recovered from the events. No product quality complaint was involved. Additional information has been requested.
GENERALIZED MALAISE; ONE BIG RASH (TURNED RED ALL OVER); FELT FEVERISH/ FEVER; This spontaneous report received from a patient via a company representative concerned a 47 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: non smoker, non alcohol user, and mildly overweight, and other pre-existing medical conditions included: The patient had no known drug allergies, did not have any history of drug abuse or illicit drug use, no known past reactions from vaccines or medication and did not have any breathing issues. The patient was doing well overall with no significant past medical history. The patient not pregnant at the time of vaccination. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose was not reported, administered on 10-SEP-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 11-SEP-2021, the patient experienced generalized malaise. On 11-SEP-2021, the patient experienced one big rash (turned red all over). On 11-SEP-2021, the patient experienced felt feverish/ fever. Laboratory data included: Body temperature (NR: not provided) 102 F. Treatment medications included: diphenhydramine hydrochloride. On 12-SEP-2021, treatment medications included: ibuprofen, and paracetamol. On 13-SEP-2021, Laboratory data included: Body temperature (NR: not provided) 100.8 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from one big rash (turned red all over) on 13-SEP-2021, and had not recovered from felt feverish/ fever, and generalized malaise. This report was non-serious.
Pt recvd DTP/HIB on 30JUL91 & approx 5 min p/vax devel a hive rash all over body; No resp sx noted; pt's MD was notified & instructed to given pt DPH & keep informed on condition;
7 days post vax pt exp an inj site rxn (erythema, tenderness & hot to touch); pt afebrile; no myalgias or arthralgias; seen in ofc 28SEP, rxn measured 3x5cm's; no tx initiate @ time of rpt; pt doesn't recall when recvd last tetanus
extreme pain, left side from back to ribs and breast.  Went to ER on 5/3/21, had EKG, CAT, ultrasounds, etc.  Diagnosis = bi-lateral pulmonary embolism.  TX = Eloquis for next 30 days.
Right upper arm w/ 4.5 cm x 4.5 cm w/erythematous patch slightly warm.
I am allergic to the flu and pneumonia vaccines; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient.  A patient (no qualifiers provided) received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13) (Batch/Lot number: unknown) as dose number unknown, single for immunisation; influenza vaccine (FLU VACCINE) (Batch/Lot number: unknown) for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ALLERGY TO VACCINE (non-serious) with onset 2021, outcome "unknown", described as "I am allergic to the flu and pneumonia vaccines". Additional information were as follows: "I am allergic to the flu and pneumonia vaccines. My doctor advised me to find out if there are any of the ingredients in the Pfizer vaccine that are in the flu and pneumonia vaccines. If not, then I will be able to take the vaccine!"  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pt was seen on 2/2/00 with local toxic reaction (6-7 cm) induration , redness & sight tenderness.
Mother reports her right arm became hardened around deltoid area, red, she applied ice to area and on 5/1/20 it was not hard anymore but can still see redness. Mild around area, bruise, no fever, pain
Server pain in left shoulder and pain in legs.  Went to ER  and they will not give me anything for pain otc meds to nothing.
Injection - site medium size bump. Recommended cold compresses and BENADRYL if necessary.
Mom states client ran fever same day of vaccine, 99 something per mom & just not feeling well.  Next day, area was red & swollen.  On 7/7/11 mom states area looks like a burn with blister.
Red spot on arm tripled in size from shoulder to 6 inches down her arm; Itching on arm; Hot as fire feeling on arm; Bruise; Sore right arm; This spontaneous case was reported by a consumer and describes the occurrence of CONTUSION (Bruise), ERYTHEMA (Red spot on arm tripled in size from shoulder to 6 inches down her arm), PRURITUS (Itching on arm), FEELING HOT (Hot as fire feeling on arm) and PAIN IN EXTREMITY (Sore right arm) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 051C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jun-2021, the patient experienced PAIN IN EXTREMITY (Sore right arm). On 02-Jul-2021, the patient experienced CONTUSION (Bruise). On 05-Jul-2021, the patient experienced ERYTHEMA (Red spot on arm tripled in size from shoulder to 6 inches down her arm), PRURITUS (Itching on arm) and FEELING HOT (Hot as fire feeling on arm). At the time of the report, CONTUSION (Bruise), ERYTHEMA (Red spot on arm tripled in size from shoulder to 6 inches down her arm), PRURITUS (Itching on arm), FEELING HOT (Hot as fire feeling on arm) and PAIN IN EXTREMITY (Sore right arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. Treatment medications included unspecified medicated lotion.
ad soreness on the left side, where they got the vaccine; within  1 week after they had the shot, various lymph nodes  had swollen really bad, a dozen of them, lymph nodes are the size of 2 to 3 cm; had a strong pretty bad  reaction/ reactive to the vaccine; affecting their sleep; is very uncomfortable; the neck is all swollen up; This spontaneous case was reported by a patient and describes the occurrence of IMMUNISATION REACTION (had a strong pretty bad  reaction/ reactive to the vaccine), SLEEP DISORDER (affecting their sleep), DISCOMFORT (is very uncomfortable), SWELLING (the neck is all swollen up) and VACCINATION SITE PAIN (ad soreness on the left side, where they got the vaccine) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 059m21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for Product used for unknown indication: Pfizer. Past adverse reactions to the above products included No adverse event with Pfizer. Concurrent medical conditions included Bee sting. Concomitant products included VITAMIN D [VITAMIN D NOS] and SILDENAFIL CITRATE (VIAGRA) for an unknown indication.    On 02-May-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-May-2022, the patient experienced VACCINATION SITE PAIN (ad soreness on the left side, where they got the vaccine). In May 2022, the patient experienced IMMUNISATION REACTION (had a strong pretty bad  reaction/ reactive to the vaccine), SLEEP DISORDER (affecting their sleep), DISCOMFORT (is very uncomfortable), SWELLING (the neck is all swollen up) and LYMPHADENOPATHY (within  1 week after they had the shot, various lymph nodes  had swollen really bad, a dozen of them, lymph nodes are the size of 2 to 3 cm). At the time of the report, IMMUNISATION REACTION (had a strong pretty bad  reaction/ reactive to the vaccine) and VACCINATION SITE PAIN (ad soreness on the left side, where they got the vaccine) outcome was unknown and SLEEP DISORDER (affecting their sleep), DISCOMFORT (is very uncomfortable), SWELLING (the neck is all swollen up) and LYMPHADENOPATHY (within  1 week after they had the shot, various lymph nodes  had swollen really bad, a dozen of them, lymph nodes are the size of 2 to 3 cm) had not resolved.            The events reported were shown up to 25-May-2022. It was reported that other physician that they spoke to, three of them, think this was a side effect, and a strong one, a severe one It was reported that one of the doctors said that has seen lymph nodes as big as them, but not so many, and has seen patient that took a long time to resolve, but not this combination of symptoms. It was reported that a Radiologist, made an ultrasound and said that they do not look like metastatic, but reactive to the vaccine. Four physician, said that, this was relative to the vaccine, and was more severe that what is found in the literature. No treatment medication was provided.   This case was linked to MOD-2022-575907, MOD-2022-576316 (Patient Link).
Patient's mom reported that patient had chest pressure and felt tired on Saturday 6/5/2021 (pt got 2nd pfizer covid 19 vaccine dose on 6/4/2021) per mom.   Pt's mom was advised to contact PCP or visit urgent care or ER if symptoms get worse.    Called pt's mom next day to follow up on pt's adverse reactions.  Pt felt better and chest pressure went away per pt's mom.
Dizziness, passing out, heart palpitations. No treatment, I was told this was normal for girls my age. Was never told it could be from the HPV vaccine.
This spontaneous report has been received from a healthcare worker concerning a patient of unknown age and gender. The patient's concomitant medication, pertinent medical history and drug reactions/allergies were not reported. On 19-JAN-2016 the patient was administered a dose of improperly stored ROTATEQ (strength, dose not reported, lot # L013202 and Exp. date 27-JAN-2017) orally. The vaccine was exposed to 34 F for 8 hours, and there was no previous temperature excursion. No adverse effect was reported. This is one of several reports received from the same reporter. Additional information has been requested.
received a bivalent dose of the vaccine as a second dose; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of WRONG PRODUCT ADMINISTERED (received a bivalent dose of the vaccine as a second dose) and NO ADVERSE EVENT (No adverse event) in a female patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (received a bivalent dose of the vaccine as a second dose) and NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (received a bivalent dose of the vaccine as a second dose) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (received a bivalent dose of the vaccine as a second dose).    No concomitant information was reported.  Reporter stated that in other facility a patient received one dose of the monovalent vaccine as a first dose of the Moderna COVID19 vaccine and as a second dose she received a bivalent dose of the vaccine.  No treatment information was provided.
Received VARIVAX 7-1-08. Redness and soreness to right upper arm 7-2-08. Presents to pediatrics 7-3-08, with increased redness, <- swelling. Per Dr exam, right upper arm with redness that extends 2/3 of the distance with a little redness below the elbow, warm, not especially swollen, not indurated except at injection site where it is tender. Treated with cephalexin 250mg/5ml. 7.5ml TID x 10days.
I guess I got the super senior flu shot because they knew my age. I never had a bad reaction before with the regular shot.
Bells Palsy; Facial numbness and drooping left side. Eye, cheek, lips.; This is a spontaneous report from a contactable nurse. A 49-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 11Jan2021 15:00 (Batch/Lot Number: EK4176) as 2nd dose, single for COVID-19 immunization. The patient had no medical history. The patient's concomitant medications were not reported. The patient previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 21Dec2020 15:30 in the left arm (lot number: EH9899). The patient did not receive any other vaccines within 4 weeks prior the COVID vaccine. The patient experienced Facial numbness and drooping left side. Eye, cheek, lips; had Bells Palsy on 30Apr2021 11:00 which resulted a visit in the emergency room or urgent care. Steroids and acyclovir were taken as treatment for the events. The patient was not diagnosed with COVID prior vaccination and has not been tested after vaccination. The outcome of the event was unknown. The event Bells Palsy was assessed as serious- medically significant.; Sender's Comments: Based on the information currently available, a possible contributory role of the suspect drug in the reported serious event cannot be completely ruled out given the known suspect drug profile and/or implied temporal association. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to the Authorities, Ethics Committees and Investigators, as appropriate.
Information has been received from a RN concerning a male who on 01Sep99 was vaccinated SC in the left arm with a 0.5ml dose of varicella virus vaccine live (lot629613/0285J). There was no concomitant medication. Subsequently, on an unspecified date, the pt experienced chickenpox with a fever. Unspecified medical attention was sought, however, no treatment was provided. The outcome was not specified by the reporter. Additional information has been requested.